Candel Therapeutics (CADL) Interest Coverage Ratio (2020 - 2025)
Candel Therapeutics (CADL) reported Interest Coverage Ratio of 27.3 for Q4 2025, up 68.14% on a YoY basis from 16.24 in Q4 2024, and down 2255.43% sequentially from 1.16 in Q3 2025.
Candel Therapeutics (CADL) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of Interest Coverage Ratio data on file, last reported at 27.3 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 68.14% year-over-year to 27.3; the trailing twelve-month figure through Dec 2025 stood at 25.76 (down 51.74% YoY), and the FY2025 full-year result was 0.74, up 38.84% from the prior year.
- Interest Coverage Ratio fell to 27.3 in Q4 2025, from 1.16 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.31 in Q1 2022 to a low of 155.79 in Q4 2022.
- A 5-year average of 21.84 and a median of 12.23 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio tumbled 37122.17% in 2022 and surged 96.74% in 2024, its largest moves.
- Tracing CADL's Interest Coverage Ratio over 5 years: stood at 0.42 in 2021, then plunged by 37122.17% to 155.79 in 2022, then surged by 88.09% to 18.56 in 2023, then sank by 361.78% to 85.69 in 2024, then surged by 68.14% to 27.3 in 2025.
- Business Quant data shows CADL's Interest Coverage Ratio at 27.3 in Q4 2025, 1.16 in Q3 2025, and 0.99 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | -27.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.30 |
| Sep 30, 2025 | -1.16 |
| Jun 30, 2025 | -0.99 |
| Mar 31, 2025 | -0.59 |
| Dec 31, 2024 | -85.69 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -12.23 |
| Dec 31, 2023 | -18.56 |
| Sep 30, 2023 | -13.25 |
| Jun 30, 2023 | -0.96 |
| Mar 31, 2023 | -15.82 |
| Dec 31, 2022 | -155.79 |
| Sep 30, 2022 | -17.11 |
| Jun 30, 2022 | -20.12 |
| Mar 31, 2022 | -0.31 |
| Dec 31, 2021 | -0.42 |
| Dec 31, 2020 | -0.54 |